ITCI - Intra-Cellular gains after late-stage win for mood disorder therapy
2024-06-18 08:06:59 ET
More on Intra-Cellular Therapies
- Intra-Cellular Therapies, Inc. (ITCI) Q1 2024 Earnings Call Transcript
- Intra-Cellular Therapies: Positive MDD Data And Commercial Momentum Make It A Buy
- Intra-Cellular: More Upside Possible Even After Positive MDD Treatment Data
- Intra-Cellular Therapies Q1 2024 Earnings Preview
- Intra-Cellular Therapies drops 2%, prices $500M equity financing